Mondobiotech Laboratories AG
Records under this name other than patents Mondobiotech Laboratories AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Mondobiotech Laboratories AG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,541,364 | Use of a octreotide as a therapeutic agent Formerly held Lapsed on the fee record Ended Sep 24, 2017 · USPTO record | Lapsed on the fee record | Ended Sep 24, 2017 | USPTO record |
| US 8,349,805 | Use of Gonadorelin as a therapeutic agent Formerly held Lapsed on the fee record Ended Jan 8, 2017 · USPTO record | Lapsed on the fee record | Ended Jan 8, 2017 | USPTO record |
| US 8,338,380 | Use of the peptide RFMWMR as a therapeutic agent Formerly held Lapsed on the fee record Ended Dec 25, 2016 · USPTO record | Lapsed on the fee record | Ended Dec 25, 2016 | USPTO record |
| US 8,211,856 | Use of somatostatin-14 as a therapeutic agent Formerly held Lapsed on the fee record Ended Jul 3, 2016 · USPTO record | Lapsed on the fee record | Ended Jul 3, 2016 | USPTO record |
| US 8,193,149 | Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicine Formerly held Lapsed on the fee record Ended Jun 5, 2016 · USPTO record | Lapsed on the fee record | Ended Jun 5, 2016 | USPTO record |